Reveleer - Comprehensive Analysis Report

Summary

Reveleer, established in 2009, is a healthcare software company focused on enabling value-based care (VBC) for healthcare providers and health plans. Formerly known as Health Data Vision, Reveleer provides a connected platform designed to deliver transparency, choice, and control within government-sponsored healthcare. The company's platform unifies data retrieval, clinical intelligence, risk adjustment, quality improvement, and member management solutions into an AI-powered system with the mission to accelerate insight-based healthcare.

1. Strategic Focus & Objectives

Core Objectives

Reveleer aims to provide a comprehensive, AI-powered platform for value-based care, addressing challenges faced by healthcare providers and health plans.

The company's objectives include unifying critical functions and streamlining operations, supporting risk adjustment, quality improvement, and member management.

It also intends to enable healthcare organizations to manage projects internally or via collaboration and allow healthcare software companies to connect and improve medical record coding accuracy, increase provider feedback, and leverage provider data.

Specialization Areas

Reveleer specializes in providing an AI-powered platform which integrates clinical intelligence, risk adjustment, quality improvement, and member management.

The company's unique value proposition lies in its ability to streamline fragmented workflows, enhance care quality, and optimize performance on value-based initiatives.

Target Markets

Reveleer's primary market segments include healthcare providers and health plans involved in value-based care arrangements with government and private payers.

Reveleer’s platform supports more than 66 million covered lives through improved care and operational efficiency.

2. Financial Overview

Funding History

Reveleer has raised a total of $162 million to $188 million over 7 funding rounds.

The most recent funding round, a Series E, occurred on February 26, 2024, securing $65 million.

Key investors in the Series E round included Hercules Capital, with participation from Oak HC/FT, Boston Millennia Partners, Redhills Ventures, and Upfront Ventures.

The company plans to use the funding to drive strategic expansion, accelerate innovation, enhance patient care through healthcare AI technology, and pursue inorganic growth opportunities in value-based care technology.

3. Product Pipeline

Key Products/Services

Clinical Intelligence: Integration of AI with EVE (Reveleer's Evidence Validation Engine), offers accurate clinical insights and intelligent automation.

Risk Adjustment: The next-generation retrospective risk solution, launched in March 2025, advances risk adjustment programs.

Quality Improvement: Reveleer's platform helps healthcare organizations improve quality scores in value-based care programs.

Member Management:Reveleer's platform enhances member engagement and streamlines workflows.

4. Technology & Innovation

Technology Stack

Reveleer's platform uses technologies like natural language processing (NLP) and artificial intelligence (AI) to automate tasks, consolidate data, and improve the accuracy of healthcare analytics.

It integrates with electronic health record (EHR) systems and health information exchanges (HIEs) to ensure data flow and enhanced provider engagement.

EVE (Evidence Validation Engine): An AI-powered engine that ensures Medical Record Review (MRR) while improving operational and financial impact without compromising compliance.

AI-powered clinical review: Provides clinical insights with up to 99% accuracy, minimizing coding errors and improving RAF capture.

Dynamic HCC validation: Real-time hierarchical dynamic validation improves efficiency without compromising compliance or increasing audit risk.

5. Leadership & Management

Executive Team

Jay Ackerman: Chief Executive Officer, President, and Chairman of the Board.

Rita Young: Chief Operating Officer, SVP of Clinical Operations and Customer Success.

Sunil Chandran: Chief Technology Officer.

Erin Lafferty: Chief Financial Officer.

Mark Eastwood: Chief Product Officer.

Paul Burke: Chief Product Officer.

David Meyer: Chief AI & Data Officer.

Peter Prucnel: Chief People Officer.

Vindya Dayananda: EVP, Corporate Development & Strategy.

Brant Castellow: EVP, Sales.

Barbara Allen: EVP, Operations.

Alan Tam: Chief Marketing Officer.

Jerry Hagan: EVP, Novillus President.

Kevin Coloton: EVP & General Manager, Clinical Intelligence.

Serafina Raskin: EVP, General Counsel.

Recent Leadership Changes

Paul Burke has been appointed as Chief Product Officer.

6. Competitive Analysis

Major Competitors

Tebra Technologies

Apixio

Centauri Health Solutions

Health Fidelity

Altegra Health

Talix

Cotiviti

Change Healthcare

Azalea Health Innovations

Avhana Health

Mingyi Zhonghe Technology

Myndshft Technologies

7. Market Analysis

Market Overview

Reveleer operates in the healthcare software market, focusing on value-based care.

The global NLP market in healthcare was valued at $2.8 billion in 2024 and is projected to reach $8.5 billion by 2029.

The value-based care market was estimated at $1.3 trillion in 2024.

8. Strategic Partnerships

Dynamic Healthcare Systems (2022): Expanded Reveleer's integrated workflow platform.

MDPortals (2023): Enhanced prospective risk platform.

Novillus (2025): Further expands Reveleer's value-based care platform.

9. Operational Insights

Reveleer's platform automates processes related to Risk Adjustment and Quality Improvement programs, enabling health plans to manage these programs in-house.